SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is attracting significant attention as investors react to a White House executive order aimed at strengthening domestic defense supply chains, which highlights the company's role in reducing reliance on foreign critical minerals. The community is actively debating the stock's long-term strategic importance alongside high short interest and anticipation for upcoming financial results.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Investors are actively debating the future of CRO amid a surge of community-led meme coin interest on the Cronos chain and ongoing concerns regarding token dilution. While some users remain optimistic about long-term institutional utility and upcoming platform enhancements, a vocal segment of the community continues to voice significant frustration over stagnant performance and the perceived impact of management's token strategy.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is seeing heightened market attention driven by anticipation around upcoming earnings and recent high-profile institutional buying from major firms. Community discourse is heavily focused on the company's role as a strategic domestic supplier of critical minerals, with investors actively discussing potential government-backed support and the impact of the ongoing critical minerals roundtable.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is seeing a surge in investor interest driven by a series of high-value strategic partnerships, including recent collaborations with Jazz Pharmaceuticals and Vertex, which validate the company's T-cell engager platform. The community is actively discussing this momentum as a potential turning point, with significant focus on the upcoming Phase 2 clinical readout for ABCL635 as a major catalyst for a possible re-rating.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is gaining momentum as investors react to positive institutional accumulation from major players like BlackRock and an Outperform rating from Wedbush. Community discussion is heavily centered on the company's progress in quantum sensing, its strategic government defense contracts, and high expectations for upcoming earnings reports.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is experiencing significant price volatility and community debate as investors weigh the potential of long-term infrastructure partnerships against frustration over current market performance. While some are accumulating tokens in anticipation of upcoming institutional integration, others are expressing concern regarding whale selling pressure and the extended timeline for project execution.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics Holdings is trending due to a significant stock offering priced at a discount, which has triggered heavy selling and sparked intense debate among investors regarding the company's long-term financial viability. The community is actively clashing over the impact of ongoing dilution versus the potential of their Eversense 365 technology, with many shareholders expressing deep frustration over management's decision-making and the stock's recent price volatility.

Airbnb, Inc. engages in the management and operation of an online marketplace. Its marketplace model connects hosts and guests online or through mobile devices to book spaces. The company was founded by Brian Chesky, Nathan Blecharczyk and Joseph Gebbia in 2007 and is headquartered in San Francisco, CA.

Airbnb Inc - Ordinary Shares - Class A

Airbnb Inc

Airbnb shares are rallying to new 52-week highs following a strong earnings beat and raised full-year guidance, with investors cheering an acceleration in booking momentum and effective AI-driven productivity gains. The community remains divided, however, as some traders highlight the stock's significant run-up and potential valuation concerns, while others focus on its success in capturing global travel demand and its emerging role as a leader in tech-integrated experiences.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is seeing intense market volatility as activist investor Russ Savage takes a notable stake and demands a leadership overhaul, including the potential removal of the current CEO following a recent earnings miss. The company is now the subject of heavy debate among traders, who are split between viewing the stock as a prime short-squeeze candidate and fearing deeper structural decline.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors digest a beat-and-raise quarterly earnings report while closely monitoring the stock's consolidation around key technical support levels. The community remains divided, with many debating the impact of recent insider purchases against long-term concerns regarding the company's growth pipeline and the potential for future M&A activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.

Albireo Pharma Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

ALBOAlbireo Pharma Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest ALBO News